Spyre Therapeutics (SYRE) Shares Outstanding (Entity) (2014 - 2026)
Spyre Therapeutics' Shares Outstanding (Entity) was 89.95 million in Q3 2026, up 48.8% from 60.47 million a year earlier and up 2.1% from the prior quarter.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Spyre Therapeutics came in at 64.42 million, up 35.7% from FY2024.
- Shares Outstanding (Entity) shows a five-year compound annual growth rate of 6.1% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 47.49 million in FY2024 (+546.9%), 7.34 million in FY2023 (-91.3%), 84.28 million in FY2022 (+28.2%) and 65.74 million in FY2021 (+37.1%).
- The Q3 2026 figure marks the highest quarterly Shares Outstanding (Entity) since Q1 2023.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for nine straight quarters, with growth averaging 101.1% over the last eight quarters.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q3 2024 (growth of 912.1%); the worst was Q3 2023 (a decline of 94.6%).
- Per Business Quant data, SYRE's Shares Outstanding (Entity) in the three quarters before Q3 2026 was 88.06 million (Q2 2026), 78.84 million (Q1 2026) and 64.42 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | 89.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 89.95 Mn |
| Jun 30, 2026 | 88.06 Mn |
| Mar 31, 2026 | 78.84 Mn |
| Dec 31, 2025 | 64.42 Mn |
| Sep 30, 2025 | 60.47 Mn |
| Jun 30, 2025 | 60.37 Mn |
| Mar 31, 2025 | 60.28 Mn |
| Dec 31, 2024 | 47.49 Mn |
| Sep 30, 2024 | 51.40 Mn |
| Jun 30, 2024 | 50.78 Mn |
| Mar 31, 2024 | 36.63 Mn |
| Dec 31, 2023 | 7.34 Mn |
| Sep 30, 2023 | 5.08 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 3.77 Mn |
| Dec 31, 2022 | 3.37 Mn |
| Sep 30, 2022 | 3.77 Mn |
| Jun 30, 2022 | 3.29 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 2.63 Mn |
API Access
Spyre Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();